Xtant Medical Holdings (XTNT) Return on Capital Employed (2011 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Return on Capital Employed came in at 36.72% in Q4 2025, up 5454.0% year-on-year from 0.66% in Q4 2024, and up 301.6% on a QoQ basis from 9.14% in Q3 2025.
Xtant Medical Holdings (XTNT) Return on Capital Employed (2011 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 15 years of Return on Capital Employed data on file, last reported at 36.72% in Q4 2025.
- On a quarterly basis, Return on Capital Employed rose 5454.0% year-over-year to 36.72% in Q4 2025; TTM through Dec 2025 was 36.72%, a 5454.0% increase from a year earlier, with the FY2025 full-year figure at 130.64%, up 14932.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 36.72%, up from 9.14% in the prior quarter.
- Over the last five years, Return on Capital Employed for XTNT reached as high as 36.72% in Q4 2025 and fell as low as 22.02% in Q3 2024.
- Historically, Return on Capital Employed has averaged 8.59% across 5 years, with a median of 14.09% in 2023.
- Across the five-year window, Return on Capital Employed tumbled 1688 bps in 2022 and surged 5454 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 8.72% in 2021, then tumbled by 80 bps to 15.74% in 2022, then grew by 7 bps to 14.65% in 2023, then fell by 22 bps to 17.82% in 2024, then jumped by 306 bps to 36.72% in 2025.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 36.72% in Q4 2025, 9.14% in Q3 2025, and 0.04% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | 36.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.72% |
| Sep 30, 2025 | 9.14% |
| Jun 30, 2025 | 0.04% |
| Mar 31, 2025 | -11.56% |
| Dec 31, 2024 | -17.82% |
| Sep 30, 2024 | -22.02% |
| Jun 30, 2024 | -20.48% |
| Mar 31, 2024 | -18.59% |
| Dec 31, 2023 | -14.65% |
| Sep 30, 2023 | -14.25% |
| Jun 30, 2023 | -13.94% |
| Mar 31, 2023 | -14.61% |
| Dec 31, 2022 | -15.74% |
| Sep 30, 2022 | -16.14% |
| Jun 30, 2022 | -15.79% |
| Mar 31, 2022 | -13.30% |
| Dec 31, 2021 | -8.72% |
| Sep 30, 2021 | -3.59% |
| Jun 30, 2021 | 1.09% |
| Mar 31, 2021 | 2.33% |